Evidence map›Paper›PMID 32464493›Full record

ArticleMedical hypotheses2020

Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.

Baris Afsar, Mehmet Kanbay, Rengin Elsurer Afsar

Open access · greenAbstract readLetter
In one paragraph

Article in Medical hypotheses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. CD73: Friend or Foe in Lung Injury.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Effects of theaflavin-gallatePhytomedicine plus : international journal of phytotherapy and phytopharmacology · 2022
    Article
  17. Review
  18. Observational
  19. Article
  20. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Baris AfsarSuleyman Demirel University, School of Medicine, Department of Internal Medicine and Nephrology, Turkey. Electronic address: afsarbrs@yahoo.com.
Mehmet KanbayKoc University, School of Medicine, Department of Internal Medicine and Nephrology, Turkey.
Rengin Elsurer AfsarSuleyman Demirel University, School of Medicine, Department of Internal Medicine and Nephrology, Turkey.
Süleyman Demirel University · TRKoç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin-Converting Enzyme 2BetacoronavirusCoronavirus InfectionsCOVID-19FerritinsHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitModels, TheoreticalPandemicsPeptidyl-Dipeptidase APneumonia, ViralProtein BindingSARS-CoV-2Treatment OutcomeACE2 protein, humanAngiotensin-Converting Enzyme 2FerritinsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitPeptidyl-Dipeptidase A

Identifiers

PMID32464493
PMCPMC7238987
OpenAlexW3024756225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.